EMA Application withdrawn: Nuzyra — Paratek Ireland Limited

View source ↗

Summary

The EMA status shows withdrawal of the Nuzyra application by Paratek Ireland Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia
• Skin Diseases

Drugs mentioned

• Nuzyra (Omadacycline)

Snippet

Status: Application withdrawn. Therapeutic area: Pneumonia, Bacterial;Skin Diseases, Bacterial. MAH: Paratek Ireland Limited